GW25-e0526 Catheter ablation of premature ventricular contractions originating in the aortic sinus cusp with Two QRS morphologies  by Yubin, Wang et al.
(n ¼5), anterior papillary muscles of left ventricular (LV-APM) (n ¼1), septal
papillary muscles of right ventricular (RV-SPM) (n¼ 1). In ﬁve patients originating
from posterior papillary muscles of left ventricular recorded Purkinje potentials at
the target, Purkinje potentials preceded QRS complex during sinus rhythm and
immersed in QRS complex during PVC. In patients originating from LV APM and
RV SPM recorded high frequency and segment potentials preceded QRS complex
during sinus rhythm. The earliest ventricular activation was recorded 22-32
(37.313.2) ms at the site of catheter ablation. During the follow up period of 6-24
(9.864.0) months after ablation,3 patients recurred and all the patients without
complications.
Conclusions: PVC arise from the papillary muscles have featured electrocardiogram
characteristics. Catheter ablation of PAP PVC is challenging, and transthoracic
echocardiography maybe helpful for ablating PVC originating from PAP.
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Objectives: The purpose of this study was to examine the electrocardiographic (ECG)
and electrophysiological characteristics for guiding catheter ablation in patients with
two morphological types of PVC originating from the aortic sinus cusp (ASC) or great
cardiac vein(GCV).
Methods: ECG analysis was performed in 10 patients with PVC with two QRS
morphologies. During and before the procedure, the patients showed a dominated type
with LBBB and an inferior axis QRS morphology and less right bundle branch block
(RBBB) morphology were divided into group 1 and a dominated type with RBBB
QRS morphology were devided in group 2. During PVC, electroanatomical mapping
was performed in both the right ventricular outﬂow tract (RVOT) and ASC in group 1,
and only performed in ASC or GCV in group 2.
Results: All patients showed two QRS morphologies (LBBB and RBBB) during
PVC, 7 of 10 patients were in group 1, 3 of 10 patients were in group 2. During
arrhythmia, the earliest ventricular activation (EVA) was recorded 276ms (range 18-
36 ms) from the RVOT and recorded 256ms (range 18-34 ms) from the ASC in
group1, EVA was recorded 28 ms, 42 ms in ASC and 34 ms in GCV in group 2. All
patients were successfully ablated ﬁnally,7 of 10 patients originated from the left
coronary cusp ( LCC), 2 of 10 patients originated left coronary cusp- right coronary
cusp commissure (L-RCC) and 1 of 10 patient originated from GCV. All arrhythmias
were successfully abolished. None of the patients had recurrence or complications
during 18.45.1 (range 6-24 months) months of follow-up.
Conclusions: Ventricular arrhythmias originating from ACS often show two QRS
morphologies on the ECG, which may be with two breakout site and only one origin.
The origin was in LCC and L-RCC commonly, mapping in the LCC and L-RCC may
be ablated successfully. The insulated myocardial ﬁber across the ventricular outﬂow
septum may exist, and could present functional conduction. Preferential conduction
not only exist between ASC and RVOT but also exist between GVC to RVOT. Two
QRS morphologies (LBBB and RBBB) during PVC maybe another predictor of the
PVC originating from ASC or GCV.
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Objectives: Cryoballoon ablation (CBA) for atrial ﬁbrillation (AF) is wide used.
However, its outcome of long-term follow-up is still seldom reported. This study is to
investigate the long-term follow-up outcome of CBA, and further to analysis the
clinical risk factors of recurrenece.
Methods: The inpatient, operating and outpatient data of patients, who were treated
by CBA for AF in our center from January 2009 to April 2013, were retrospective
analyzed. Left atrium diameter (LAD) was measured by transthoracic echocardiog-
raphy. Failure-treatment of CBA was deﬁned by episode of AF, atrial ﬂutter, atrial
tachycardia lasted for 30 seconds after 3 months or persistent atrial arrhythmia which
needed to re-ablated during 3 months after CBA.
Results: A total of 199 patients were received 217 times CBA, and 18 patients were
received re-CBA. The incidence rates of phrenic nerve paralysis, pericardial effusion,
transient ischemic attack were 1.5% (n¼3), 0.5% (n¼1), 0.5% (n¼1), respectively. All
complications were resolved spontaneously. During a long-term follow-up of mean
2314 months, 149 patients had complete follow-up data, the treated success rate of
ﬁrst-time CBA and all CBA were 42.8% and 47.2%, respectively. The patients who
experienced the atrial arrhythmia recurrence in ﬁrst 12 month occupied 86.1% in all
failure-treated patients. The characteristics of failure-treated patients included with
more persistent AF (39.1% vs. 18.6%, P¼0.0058) and larger LAD (486 mm vs.
436 mm, P<0.0001). The Logistic analysis showed that LAD [OR¼0.896 (0.842,
0.953), P¼0.005] and age [OR¼1.037 (1.000, 1.076), P¼0.0488] could individually
predict the treat-failure after ﬁrst CBA, and only LAD [OR¼0.876 (0.822, 0.935),
P<0.0001] could individually predict the total CBA.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CConclusions: CBA procedure for AF is safe and effective although the result of long-
term follow-up is preferable. Most of atrial arrhythmia are recurred during ﬁrst 12
month after CBA. LAD can individually predicted for failure-treatment of CBA.
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Objectives: A new second generation cryoballoon (G2) is design to release more
coldly temperature and to archive more rapidly pulmonary vein isolation (PVI).
However, whether its design can improve the long-term outcome of cryoablation for
patients with atrial ﬁbrillation (AF) is unknown. This study is to investigate whether
the G2 cryoballoon could improve the outcome of long-term follow-up of AF patients
by compared to a ﬁrst generation cryoballoon (G1).
Methods: The cryoablation and follow-up data of patients who were ﬁrst-time treated
for AF by a 28 mm cryoballoon from January 2012 to June 2013 in our center were
analyzed. According to the different cryoballoon used, the patients were divided to
two groups, the G1 group which treated by the ﬁrst generation cryoballoon (Arctic-
Front) and the G2 group which treated by the second generation cryoballoon (Arc-
ticFront Advance). The failure treatment of cryoablation was deﬁned as any detected
episode of AF, atrial ﬂutter, atrial tachycardia which lasted for 30 seconds after
3 months later post cryoabaltion. Left atrium diameter (LAD) was measured by
transthoracic echocardiography before cryoablation.
Results: A total of 105 patients (G1/G2 group: n¼57/48) were enrolled in this study.
The success rate of immediately PVI in the G2 group was higher than that in the G1
group [98.7 % (150/152) vs. 94.6 % (174/184), P¼0.0429]. The mean minimum
temperatures attained in the G2 group during different pulmonary vein cryoablation
were lower than that in the G1 group (P<0.01). The mean cryomapping time (30 [16,
44] min vs. 35 [25, 55]min, P<0.0001), the mean total procedure time (105 [75, 145]
min vs. 120 [80, 190]min, P¼0.0056) and the mean total X ray exposure time (17 [13,
28] min vs. 20 [13, 32] min, P¼0.0470) in the G2 group were shorter than that in the
G1 group. One patient in the G1 group occurred cardiac infusion during atrial septum
puncture. In the G2 group, two patients occurred transient phrenic nerve paralysis,
other two patients occurred transient ischemic attack, and all above patients were
recovery. During mean 13 [5, 20] months follow-up, a total of 73 patients had
complete follow-up data, and 46 (63.0%) patients were maintained sinus rhythm. The
treat-failure patients were characterized with larger LAD (487mm vs. 446mm,
P¼0.0079). The success rate of cryoablation in the G2 group was higher than that in
the G1 group [89.3% (25/28) vs. 46.7 %( 21/45), P¼0.0002], and it was been testiﬁed
by further Kaplan-Meier survival analysis regarding to different follow-up time
(Log-Rank¼5.0238, P¼0.0250). The multivariate stepwise regression showed that the
new generation cryoballoon was individually related with long-term outcome of
cryoablation [RR¼9.524 (2.511, 36.121), P¼0.0009].
Conclusions: The new generation cryoballoon ablation for AF can archived not only
with lower time of cryomapping, cryoabaltion, whole procedure and higher PVI
success rate, but also with better long-term outcome than the ﬁrst generation cry-
oabaltion. However, a higher major complication seem to occur on the beginning
stage of new generation cryoballoon application.
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Objectives: Using ILR tracing atrial ﬁbrillation patient who has been successfully
accepted standard radiofrequency ablation. To evaluate the application value of ILR in
the diagnosis and evaluation of curative effect in atrial ﬁbrillation.
Methods: Collected from May 2009 to August 2013, 25 cases of patients with
atrial ﬁbrillation, 16 males and 9 females, average 55.311.9 years old. Including
15 cases of paroxysmal atrial ﬁbrillation, persistent atrial ﬁbrillation 10cases.
14 patients choose Medtronic RevealRDX9528 ILR, 11cases choose Reveal
XTTM9529 ILR. Take outpatient follow-up, holter monitoring, electrocardiogram
and telephone inquiries and other regular or irregular follow-up methods. Record
patient clinical manifestations, the ILR provides arrhythmias discretion to adjust
the medications and other therapeutic interventions. According to the conventional
methods of the ILR implantation in patients with left parasternal anterior chest
wall. In order to better track the therapeutic efﬁcacy of radiofrequency ablation
in atrial ﬁbrillation, adopt outpatient service, local doctors to assist, telephone
inquiry mode, recording patients informations such as clinical manifestations and
arrhythmia.
Results: (1) All 25 patients were successfully implanted ILR, no pocket infection,
bleeding complications. Patients were followed up for 6-47 months (mean
19.311.6). (2) The follow-up period in 25 patients ILR is manual/automatic
recording 709 times, which triggered manually record 45 times (6.3%), ILR trigger
automatically record 664 times (93.7%). (3) In the 542 times ECG recorded:sinus
bradycardia 40 times (7.4%), 51 times room sex is tachycardia (9.4%), atrial ﬂutter 24
times (4.4%), atrial ﬁbrillation 61 times (11.3%), ventricular tachycardia 27 timesardiovascular Disease Clinical Research C165
